Michael Mehler

Michael Mehler is a senior director at AstraZeneca, focusing on cell therapy strategy and partnerships. With over 15 years of experience in the industry, they have significantly advanced patient access to innovative treatments through their roles in various organizations, including Adaptimmune, GSK, and Immatics. Earlier in their career, Michael worked as a research study associate at Stanford University and the National Comprehensive Cancer Network, managing clinical oncology studies and contributing to protocol development. They hold a degree from San Jose State University, further enhancing their expertise in clinical research and operations.